Novo Nordisk and Sanofi Raising Insulin Prices

Novo Nordisk and Sanofi Raising Insulin Prices

As reported by Alia Paavola for Becker’s Hospital Review, Despite public outrage over the high cost of insulin and drugmaker promises to halt price increases, they continued to climb from 2017 to 2018, according to a GoodRx analysis. Here are seven things to know...
Belviq Outcomes Study Results: Obesity Drug Safe For the Heart

Belviq Outcomes Study Results: Obesity Drug Safe For the Heart

Carly Helfand of FiercePharma writes that Eisai’s 12,000 patient cardiovascular outcomes study has demonstrated that the drug Belviq is “heart-safe.”  Helfand reports Eisai touted that the study represented “the largest to date for a weight-loss drug.” The results of...

Pin It on Pinterest